Listen "COVID Vaccine Realities for 2025–26"
Episode Synopsis
Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season. Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient.
Guest speakers:
John Schoen, PharmD, BCPS
Senior Clinical Manager of Drug Information
Vizient Center for Pharmacy Practice Excellence
Host:
Stacy Lauderdale, PharmD, BCPS
Associate Vice President
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[01:38-05:32] What changed in the recent CDC update for healthy children
[05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children
[09:33-11:47] Specific risk factors for pediatric patients
[11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women?
[12:48-14:03] The FDA’s proposed regulatory framework for COVID-19 vaccine approval
[14:04-15:18] FDA’s approach to implementing revised requirements for randomized controlled trials
[15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee
[17:00-18:27] Topics requiring further clarification about COVID-19 vaccine
Links | Resources:
Vizient resources:
Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668
Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336
Additional resources:
FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929
ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html
CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/
WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths
MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months: https://www.cdc.gov/mmwr/volumes/73/wr/mm7338a1.htm?utm_source=chatgpt.com
MMWR – MIS-C, US 2023: https://www.cdc.gov/mmwr/volumes/73/wr/mm7310a2.htm
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Spotify
Android
RSS Feed
Guest speakers:
John Schoen, PharmD, BCPS
Senior Clinical Manager of Drug Information
Vizient Center for Pharmacy Practice Excellence
Host:
Stacy Lauderdale, PharmD, BCPS
Associate Vice President
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[01:38-05:32] What changed in the recent CDC update for healthy children
[05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children
[09:33-11:47] Specific risk factors for pediatric patients
[11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women?
[12:48-14:03] The FDA’s proposed regulatory framework for COVID-19 vaccine approval
[14:04-15:18] FDA’s approach to implementing revised requirements for randomized controlled trials
[15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee
[17:00-18:27] Topics requiring further clarification about COVID-19 vaccine
Links | Resources:
Vizient resources:
Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668
Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336
Additional resources:
FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929
ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html
CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html
CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/
WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths
MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months: https://www.cdc.gov/mmwr/volumes/73/wr/mm7338a1.htm?utm_source=chatgpt.com
MMWR – MIS-C, US 2023: https://www.cdc.gov/mmwr/volumes/73/wr/mm7310a2.htm
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Spotify
Android
RSS Feed
More episodes of the podcast VerifiedRx
Challenges with AI in Pharmacy
28/10/2025
Tapping into NTAP
30/09/2025
GLN Changes You Can’t Ignore
16/09/2025
Inside the New Joint Commission Manual
26/08/2025
Built to Last: Rx for Resilience
24/06/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.